CN111562203A - 来自小样品体积的成形血液组分沉降速率的快速测量 - Google Patents
来自小样品体积的成形血液组分沉降速率的快速测量 Download PDFInfo
- Publication number
- CN111562203A CN111562203A CN202010107295.8A CN202010107295A CN111562203A CN 111562203 A CN111562203 A CN 111562203A CN 202010107295 A CN202010107295 A CN 202010107295A CN 111562203 A CN111562203 A CN 111562203A
- Authority
- CN
- China
- Prior art keywords
- sample
- centrifuge
- hematocrit
- sedimentation
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004062 sedimentation Methods 0.000 title claims abstract description 172
- 239000012503 blood component Substances 0.000 title claims abstract description 92
- 238000005259 measurement Methods 0.000 title claims abstract description 78
- 238000000034 method Methods 0.000 claims abstract description 157
- 238000005534 hematocrit Methods 0.000 claims abstract description 136
- 210000004369 blood Anatomy 0.000 claims abstract description 104
- 239000008280 blood Substances 0.000 claims abstract description 104
- 238000005119 centrifugation Methods 0.000 claims abstract description 73
- 238000005056 compaction Methods 0.000 claims description 38
- 238000012937 correction Methods 0.000 claims description 29
- 238000012545 processing Methods 0.000 claims description 27
- 238000001514 detection method Methods 0.000 claims description 17
- 238000000926 separation method Methods 0.000 claims description 16
- 238000012544 monitoring process Methods 0.000 claims description 4
- 210000003743 erythrocyte Anatomy 0.000 abstract description 92
- 238000003384 imaging method Methods 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 29
- 238000010191 image analysis Methods 0.000 abstract description 5
- 239000000523 sample Substances 0.000 description 172
- 210000002381 plasma Anatomy 0.000 description 57
- 239000000306 component Substances 0.000 description 21
- 108010049003 Fibrinogen Proteins 0.000 description 20
- 102000008946 Fibrinogen Human genes 0.000 description 20
- 229940012952 fibrinogen Drugs 0.000 description 20
- 210000000265 leukocyte Anatomy 0.000 description 19
- 238000012360 testing method Methods 0.000 description 18
- 230000008859 change Effects 0.000 description 14
- 210000004180 plasmocyte Anatomy 0.000 description 14
- 230000009466 transformation Effects 0.000 description 14
- 230000000007 visual effect Effects 0.000 description 13
- 230000036962 time dependent Effects 0.000 description 11
- 238000003556 assay Methods 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 238000005286 illumination Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 238000007781 pre-processing Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 102000001554 Hemoglobins Human genes 0.000 description 7
- 108010054147 Hemoglobins Proteins 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 229910005540 GaP Inorganic materials 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 238000000691 measurement method Methods 0.000 description 6
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 5
- 238000000429 assembly Methods 0.000 description 5
- 230000000712 assembly Effects 0.000 description 5
- 210000001772 blood platelet Anatomy 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 230000005499 meniscus Effects 0.000 description 5
- 102000004506 Blood Proteins Human genes 0.000 description 4
- 108010017384 Blood Proteins Proteins 0.000 description 4
- 108010074051 C-Reactive Protein Proteins 0.000 description 4
- 102100032752 C-reactive protein Human genes 0.000 description 4
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000007620 mathematical function Methods 0.000 description 4
- 238000009987 spinning Methods 0.000 description 4
- 229910002601 GaN Inorganic materials 0.000 description 3
- FTWRSWRBSVXQPI-UHFFFAOYSA-N alumanylidynearsane;gallanylidynearsane Chemical compound [As]#[Al].[As]#[Ga] FTWRSWRBSVXQPI-UHFFFAOYSA-N 0.000 description 3
- 238000000149 argon plasma sintering Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- HZXMRANICFIONG-UHFFFAOYSA-N gallium phosphide Chemical compound [Ga]#P HZXMRANICFIONG-UHFFFAOYSA-N 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- -1 plasma Chemical compound 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- JMASRVWKEDWRBT-UHFFFAOYSA-N Gallium nitride Chemical compound [Ga]#N JMASRVWKEDWRBT-UHFFFAOYSA-N 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 206010039238 Rouleaux formation Diseases 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910052738 indium Inorganic materials 0.000 description 2
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910001507 metal halide Inorganic materials 0.000 description 2
- 150000005309 metal halides Chemical class 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- IHGSAQHSAGRWNI-UHFFFAOYSA-N 1-(4-bromophenyl)-2,2,2-trifluoroethanone Chemical compound FC(F)(F)C(=O)C1=CC=C(Br)C=C1 IHGSAQHSAGRWNI-UHFFFAOYSA-N 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000030289 Lymphoproliferative disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010061952 Orosomucoid Proteins 0.000 description 1
- 102000012404 Orosomucoid Human genes 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 208000008601 Polycythemia Diseases 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000011166 aliquoting Methods 0.000 description 1
- RNQKDQAVIXDKAG-UHFFFAOYSA-N aluminum gallium Chemical compound [Al].[Ga] RNQKDQAVIXDKAG-UHFFFAOYSA-N 0.000 description 1
- AJGDITRVXRPLBY-UHFFFAOYSA-N aluminum indium Chemical compound [Al].[In] AJGDITRVXRPLBY-UHFFFAOYSA-N 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 238000005136 cathodoluminescence Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000001446 dark-field microscopy Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 238000003708 edge detection Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 208000009601 hereditary spherocytosis Diseases 0.000 description 1
- 229940099472 immunoglobulin a Drugs 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000007562 laser obscuration time method Methods 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D21/00—Separation of suspended solid particles from liquids by sedimentation
- B01D21/30—Control equipment
- B01D21/32—Density control of clear liquid or sediment, e.g. optical control ; Control of physical properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D21/00—Separation of suspended solid particles from liquids by sedimentation
- B01D21/26—Separation of sediment aided by centrifugal force or centripetal force
- B01D21/262—Separation of sediment aided by centrifugal force or centripetal force by using a centrifuge
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D21/00—Separation of suspended solid particles from liquids by sedimentation
- B01D21/30—Control equipment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/04—Investigating sedimentation of particle suspensions
- G01N15/05—Investigating sedimentation of particle suspensions in blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/491—Blood by separating the blood components
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5021—Test tubes specially adapted for centrifugation purposes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/04—Investigating sedimentation of particle suspensions
- G01N15/05—Investigating sedimentation of particle suspensions in blood
- G01N2015/055—Investigating sedimentation of particle suspensions in blood for hematocrite determination
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Ecology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461930432P | 2014-01-22 | 2014-01-22 | |
| US61/930,432 | 2014-01-22 | ||
| CN201580015419.7A CN106170696B (zh) | 2014-01-22 | 2015-01-22 | 来自小样品体积的成形血液组分沉降速率的快速测量 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201580015419.7A Division CN106170696B (zh) | 2014-01-22 | 2015-01-22 | 来自小样品体积的成形血液组分沉降速率的快速测量 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111562203A true CN111562203A (zh) | 2020-08-21 |
Family
ID=53681947
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010107295.8A Pending CN111562203A (zh) | 2014-01-22 | 2015-01-22 | 来自小样品体积的成形血液组分沉降速率的快速测量 |
| CN201580015419.7A Active CN106170696B (zh) | 2014-01-22 | 2015-01-22 | 来自小样品体积的成形血液组分沉降速率的快速测量 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201580015419.7A Active CN106170696B (zh) | 2014-01-22 | 2015-01-22 | 来自小样品体积的成形血液组分沉降速率的快速测量 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP3097415A4 (es) |
| JP (3) | JP2017504027A (es) |
| CN (2) | CN111562203A (es) |
| CA (1) | CA2936828A1 (es) |
| MX (2) | MX2016009516A (es) |
| WO (1) | WO2015112768A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106446582A (zh) * | 2016-10-18 | 2017-02-22 | 江西博瑞彤芸科技有限公司 | 图像处理方法 |
| GB2555402B (en) * | 2016-10-24 | 2019-10-23 | Entia Ltd | A system and method for fluid analysis |
| WO2018132619A1 (en) * | 2017-01-11 | 2018-07-19 | Hemodus Medical, Llc | Method of estimating blood volume |
| JP7037324B2 (ja) * | 2017-01-27 | 2022-03-16 | 日本光電工業株式会社 | 炎症マーカー測定方法、炎症マーカー測定装置、炎症マーカー測定プログラム、および当該プログラムを記録した記録媒体 |
| NO346147B1 (en) * | 2017-11-09 | 2022-03-21 | Spinchip Diagnostics As | Method and apparatus for controlling a focus point of stationary beam focusing on a sample in a rotating cartridge placed in a rotating disc |
| GB2573126B (en) * | 2018-04-24 | 2022-11-09 | Entia Ltd | A method and apparatus for determining haemoglobin concentration |
| EP3820589B1 (en) * | 2018-07-09 | 2023-08-30 | Laboratory Corporation of America Holdings | Devices and methods for plasma separation and storage |
| CN111198262B (zh) * | 2018-11-19 | 2023-04-11 | 苏州迈瑞科技有限公司 | 一种用于尿液有形成分分析仪的检测装置及方法 |
| JP7413692B2 (ja) | 2019-09-25 | 2024-01-16 | 東ソー株式会社 | 細胞を含む試料の前処理方法 |
| CN111537409B (zh) * | 2020-05-06 | 2022-10-14 | 南京邮电大学 | 一种高精度血沉温度补偿测量方法与装置 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996039618A1 (en) * | 1995-06-06 | 1996-12-12 | Brigham And Women's Hospital | Determining erythrocyte sedimentation rate and hematocrit |
| EP1063513A2 (en) * | 1999-06-22 | 2000-12-27 | Wardlaw, Stephen Clark | Method and apparatus for timing intermittant illumination of a sample tube positioned on a centrifuge platen and for calibrating a sample tube imaging system |
| EP1063515A2 (en) * | 1999-06-25 | 2000-12-27 | Wardlaw, Stephen Clark | Rapid method for determining the erythrocyte sedimentation rate in a sample of anticoagulated whole blood |
| US6403328B1 (en) * | 1998-03-05 | 2002-06-11 | Roger Clampitt | Method of measuring erythrocyte sedimentation rate (ESR) or plasma fibrinogen of a blood sample |
| US20130078733A1 (en) * | 2011-09-25 | 2013-03-28 | Theranos, Inc., a Delaware Corporation | Systems and methods for fluid handling |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4197735A (en) * | 1978-11-06 | 1980-04-15 | Chase Instruments Corporation | Blood sedimentation rate test means |
| CA2230222A1 (en) * | 1997-03-10 | 1998-09-10 | Stephen C. Wardlaw | Method and assembly for rapid measurement of cell layers |
| CN1256587C (zh) * | 2004-05-31 | 2006-05-17 | 苏州市第二人民医院 | 血液流变全血质控物及其制备方法 |
| ITUD20050118A1 (it) * | 2005-07-13 | 2007-01-14 | Sire Analytical Systems Srl | Procedimento per la taratura di macchine per l' analisi di parametri del sangue connessi alla densita' del sangue, quali la velocita' di eritrosedimentazione e/o di aggregazione dei globuli rossi |
| US20110226045A1 (en) * | 2009-11-25 | 2011-09-22 | Mcquillan Adrian Charles | Liquid analysis system |
-
2015
- 2015-01-22 MX MX2016009516A patent/MX2016009516A/es unknown
- 2015-01-22 EP EP15740716.4A patent/EP3097415A4/en not_active Withdrawn
- 2015-01-22 WO PCT/US2015/012537 patent/WO2015112768A1/en active Application Filing
- 2015-01-22 CA CA2936828A patent/CA2936828A1/en not_active Abandoned
- 2015-01-22 JP JP2016547876A patent/JP2017504027A/ja not_active Withdrawn
- 2015-01-22 CN CN202010107295.8A patent/CN111562203A/zh active Pending
- 2015-01-22 CN CN201580015419.7A patent/CN106170696B/zh active Active
-
2016
- 2016-07-21 MX MX2021013459A patent/MX2021013459A/es unknown
-
2019
- 2019-12-26 JP JP2019236592A patent/JP2020046442A/ja not_active Withdrawn
-
2022
- 2022-01-06 JP JP2022000958A patent/JP2022043307A/ja active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996039618A1 (en) * | 1995-06-06 | 1996-12-12 | Brigham And Women's Hospital | Determining erythrocyte sedimentation rate and hematocrit |
| US6403328B1 (en) * | 1998-03-05 | 2002-06-11 | Roger Clampitt | Method of measuring erythrocyte sedimentation rate (ESR) or plasma fibrinogen of a blood sample |
| EP1063513A2 (en) * | 1999-06-22 | 2000-12-27 | Wardlaw, Stephen Clark | Method and apparatus for timing intermittant illumination of a sample tube positioned on a centrifuge platen and for calibrating a sample tube imaging system |
| EP1063515A2 (en) * | 1999-06-25 | 2000-12-27 | Wardlaw, Stephen Clark | Rapid method for determining the erythrocyte sedimentation rate in a sample of anticoagulated whole blood |
| US6204066B1 (en) * | 1999-06-25 | 2001-03-20 | Robert A. Levine | Rapid method for determining the erythrocyte sedimentation rate in a sample of anticoagulated whole blood |
| US20130078733A1 (en) * | 2011-09-25 | 2013-03-28 | Theranos, Inc., a Delaware Corporation | Systems and methods for fluid handling |
Non-Patent Citations (1)
| Title |
|---|
| YVES PAWLOTSKY ET AL.: "An Erythrocyte Sedimentation Rate Adjusted for the Hematocrit and Hemoglobin Concentration", 《AMERICAN SOCIETY FOR CLINICAL PATHOLOGY》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2021013459A (es) | 2021-12-10 |
| WO2015112768A1 (en) | 2015-07-30 |
| CN106170696B (zh) | 2020-03-20 |
| MX2016009516A (es) | 2016-10-26 |
| EP3097415A4 (en) | 2017-11-29 |
| CA2936828A1 (en) | 2015-07-30 |
| EP3097415A1 (en) | 2016-11-30 |
| JP2020046442A (ja) | 2020-03-26 |
| CN106170696A (zh) | 2016-11-30 |
| JP2017504027A (ja) | 2017-02-02 |
| JP2022043307A (ja) | 2022-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110187089B (zh) | 快速测量小容量样本中有形血液成分的沉降率 | |
| CN106170696B (zh) | 来自小样品体积的成形血液组分沉降速率的快速测量 | |
| US10012638B2 (en) | Rapid measurement of formed blood component sedimentation rate from small sample volumes | |
| EP2875146B1 (en) | Low-volume coagulation assay | |
| JP5254441B2 (ja) | フロー式粒子画像解析方法及び装置 | |
| Hendrix et al. | Extracellular vesicle analysis | |
| JP2020134341A (ja) | 測定成否判定方法および試料測定装置 | |
| JP7452544B2 (ja) | 情報処理装置およびプログラム | |
| WO2022009104A2 (en) | Focusing a microscope using fluorescent images |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |